Lantern Pharma, Inc. (LTRN)
2.43
+0.10
(+4.29%)
USD |
NASDAQ |
Apr 15, 16:00
2.43
0.00 (0.00%)
After-Hours: 20:00
Lantern Pharma Research and Development Expense (Annual) : 11.51M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.754B |
| BioVie, Inc. | 9.267M |
| Acurx Pharmaceuticals, Inc. | 1.834M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |